PARCCS: A Machine Learning Risk-Prediction Model for Acute Peripartum Cardiovascular Complications During Delivery Admissions
- PMID: 39135918
- PMCID: PMC11318475
- DOI: 10.1016/j.jacadv.2024.101095
PARCCS: A Machine Learning Risk-Prediction Model for Acute Peripartum Cardiovascular Complications During Delivery Admissions
Abstract
Background: Maternal mortality in the United States remains high, with cardiovascular (CV) complications being a leading cause.
Objectives: The purpose of this paper was to develop the PARCCS (Prediction of Acute Risk for Cardiovascular Complications in the Peripartum Period Score) for acute CV complications during delivery.
Methods: Data from the National Inpatient Sample (2016-2020) and International Classification of Diseases, Tenth Revision codes to identify delivery admissions were used. Acute CV/renal complications were defined as a composite of pre-eclampsia/eclampsia, peripartum cardiomyopathy, renal complications, venous thromboembolism, arrhythmias, and pulmonary edema. A risk prediction model, PARCCS, was developed using machine learning consisting of 14 variables and scored out of 100 points.
Results: Of the 2,371,661 pregnant patients analyzed, 7.0% had acute CV complications during delivery hospitalization. Patients with CV complications had a higher prevalence of comorbidities and were more likely to be of Black race and lower income. The PARCCS variables included electrolyte imbalances (13 points [p]), age (3p for age <20 years), cesarean delivery (4p), obesity (5p), pre-existing heart failure (28p), multiple gestations (4p), Black race (2p), gestational hypertension (3p), low income (1p), gestational diabetes (2p), chronic diabetes (6p), prior stroke (22p), coagulopathy (5p), and nonelective admission (2p). Using the validation set, the performance of the model was evaluated with an area under the receiver-operating characteristic curve of 0.68 and a 95% CI of 0.67 to 0.68.
Conclusions: PARCCS has the potential to be an important tool for identifying pregnant individuals at risk of acute peripartum CV complications at the time of delivery. Future studies should further validate this score and determine whether it can improve patient outcomes.
Keywords: CVD; cardiovascular disease; machine learning; preeclampsia; risk prediction.
© 2024 The Authors.
Conflict of interest statement
Dr Michos is supported by the Amato Fund for Women’s Cardiovascular Health Research at 10.13039/100005542Johns Hopkins University and by an 10.13039/100000968American Heart Association grant (946222). Dr Hays is supported in part by 10.13039/100000050NHLBI grant R01HL159715. Dr Minhas is supported by 10.13039/100000002NIH grant KL2TR003099. Dr Michos has done consulting for Amgen, Arrowhead, AstraZeneca, Boehringer Ingelheim, Edwards Lifesciences, Esperion, Ionis, Medtronic, Merck, Novartis, Novo Nordisk, and Pfizer. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.
Figures





Comment in
-
Can Artificial Intelligence Make Maternal Cardiac Risk Prediction a Walk in the Park?JACC Adv. 2024 Jul 19;3(8):101100. doi: 10.1016/j.jacadv.2024.101100. eCollection 2024 Aug. JACC Adv. 2024. PMID: 39156116 Free PMC article.
Similar articles
-
Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone.Clin Orthop Relat Res. 2024 Dec 1;482(12):2193-2208. doi: 10.1097/CORR.0000000000003185. Epub 2024 Jul 23. Clin Orthop Relat Res. 2024. PMID: 39051924
-
Development and Validation of a Predictive Model for Maternal Cardiovascular Morbidity Events in Patients With Hypertensive Disorders of Pregnancy.Anesth Analg. 2025 Aug 1;141(2):352-362. doi: 10.1213/ANE.0000000000007278. Epub 2024 Nov 6. Anesth Analg. 2025. PMID: 39504272
-
Metformin for women who are overweight or obese during pregnancy for improving maternal and infant outcomes.Cochrane Database Syst Rev. 2018 Jul 24;7(7):CD010564. doi: 10.1002/14651858.CD010564.pub2. Cochrane Database Syst Rev. 2018. PMID: 30039871 Free PMC article.
-
Thromboprophylaxis during pregnancy and the puerperium: a systematic review and economic evaluation to estimate the value of future research.Health Technol Assess. 2024 Mar;28(9):1-176. doi: 10.3310/DFWT3873. Health Technol Assess. 2024. PMID: 38476084 Free PMC article.
-
[Volume and health outcomes: evidence from systematic reviews and from evaluation of Italian hospital data].Epidemiol Prev. 2013 Mar-Jun;37(2-3 Suppl 2):1-100. Epidemiol Prev. 2013. PMID: 23851286 Italian.
Cited by
-
Can Artificial Intelligence Make Maternal Cardiac Risk Prediction a Walk in the Park?JACC Adv. 2024 Jul 19;3(8):101100. doi: 10.1016/j.jacadv.2024.101100. eCollection 2024 Aug. JACC Adv. 2024. PMID: 39156116 Free PMC article.
-
The Impact of Artificial Intelligence on Women's Cardiovascular Disease Care.Curr Cardiol Rep. 2025 Jun 20;27(1):98. doi: 10.1007/s11886-025-02250-7. Curr Cardiol Rep. 2025. PMID: 40540063 Review.
References
-
- Mehta L.S., Warnes C.A., Bradley E., et al. Cardiovascular considerations in caring for pregnant patients: a scientific statement from the American heart association. Circulation. 2020;141:e884–e903. - PubMed
-
- National Center for Health Statistics . 2022. A Reference Guide for Certification Of Deaths Associated With Pregnancy On Death Certificates.
Grants and funding
LinkOut - more resources
Full Text Sources